Treatments that aim to enhance on those drug shortcomings have been just lately approved. Quite possibly the most promising new antidepressant treatments come from a class of drugs called N-methyl-d-aspartate (NMDA) receptor antagonists. The result they have got in the Mind is different from that of other antidepressants.Hence, systemic ketamine ad